Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02059057 · ClinicalTrials.gov registry record · NA
LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)
A NA study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT02059057: Clinical Trial NA study, sponsored by Boston Scientific Corporation.
NCT02059057 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02059057, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
Crossover study for patients who were randomized to the Control Group in CLN0009 (NCT01608490).
Primary Outcome
Mean absolute change from baseline to12 months. The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.
Interventions
- DEVICE LVRC System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-07-26 |
| Phase | NA |
Why NCT02059057 stopped before completion
NCT02059057 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which LVRC System is the first listed.
NCT02059057 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02059057 about?
NCT02059057 is a clinical study titled "LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)". Crossover study for patients who were randomized to the Control Group in CLN0009 (NCT01608490).
What is the current status of trial NCT02059057?
This trial is currently terminated. It is a NA study. The enrollment target is 102 participants. The study started on 2013-12. Estimated completion is 2019-07-26.
What interventions are being tested in trial NCT02059057?
The interventions under investigation include: LVRC System (DEVICE).
Who is sponsoring clinical trial NCT02059057?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02059057's enrollment target sits among peer trials
102 837th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia